Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 62
Number of items: 62
  • Open Access
    Levi, M. (2011). Treatment with recombinant human activated protein C: one size does not fit all. Critical Care Forum, 15(1), 105. https://doi.org/10.1186/cc9375
  • Open Access
    Sivapalaratnam, S., Motazacker, M. M., Maiwald, S., Hovingh, G. K., Kastelein, J. J. P., Levi, M., Trip, M. D., & Dallinga-Thie, G. M. (2011). Genome-wide association studies in atherosclerosis. Current atherosclerosis reports, 13(3), 225-232. https://doi.org/10.1007/s11883-011-0173-4
  • Open Access
    Scheffer, A. C. L. (2011). Fear of falling in older patients. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Buurman, B. M. (2011). Screening, geriatric assessment and intervention strategies to prevent functional decline in hospitalized older patients. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    Levi, M. (2010). Adequate thromboprophylaxis in critically ill patients. Critical Care, 14(2), 142. https://doi.org/10.1186/cc8949
  • Open Access
    Schouten, M., van der Sluijs, K. F., Gerlitz, B., Grinnell, B. W., Roelofs, J. J. T. H., Levi, M. M., van 't Veer, C., & van der Poll, T. (2010). Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study. Critical Care, 14(2), R65. https://doi.org/10.1186/cc8964
  • Open Access
    Schouten, M., van 't Veer, C., Roelofs, J. J. T. H., Levi, M., & van der Poll, T. (2010). Impact of the factor V Leiden mutation on the outcome of pneumococcal pneumonia: a controlled laboratory study. Critical Care, 14(4), Article R145. https://doi.org/10.1186/cc9213
  • Open Access
    Hovius, J. W. R., Bijlsma, M. F., van der Windt, G. J. W., Wiersinga, W. J., Boukens, B. J. D., Coumou, J., Oei, A., de Beer, R., de Vos, A. F., van 't Veer, C., van Dam, A. P., Wang, P., Fikrig, E., Levi, M. M., Roelofs, J. J. T. H., & van der Poll, T. (2009). The urokinase receptor (uPAR) facilitates clearance of Borrelia burgdorferi. PLoS Pathogens, 5(5), Article e1000447. https://doi.org/10.1371/journal.ppat.1000447
  • Open Access
    Schultz, M. J., Dixon, B., & Levi, M. M. (2009). The pulmonary protein C system: preventive or therapeutic target in acute lung injury? Thorax, 64(2), 95-97. https://doi.org/10.1136/thx.2008.106955
  • Open Access
    van Geest-Daalderop, J. H. H., Hutten, B. A., Péquériaux, N. C. V., Levi, M. M., & Sturk, A. (2009). Improvement in the regulation of the vitamin K antagonist acenocoumarol after a standard initial dose regimen: prospective validation of a prescription model. Journal of Thrombosis and Thrombolysis, 27(2), 207-214. https://doi.org/10.1007/s11239-008-0203-4
Page 2 of 7